myBiometry

Remote asthma monitoring platform using proprietary FeNO sensors and predictive analytics

Built from URL

HealthcareMedical DevicesDigital healthAIHealthTechWearables

MassChallengeBoston 2020 (finalists)

AboutBuilt from URL

myBiometry develops a platform to remotely monitor and manage patients with chronic conditions using proprietary sensors and biomarker data. Their initial focus is on asthma, where they monitor Fractional Exhaled Nitric Oxide (FeNO) to determine medication adherence, efficacy, and attack risk.

ProblemBuilt from URL

See something off about this company?